Bailard Inc. Invests $204,000 in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bailard Inc. purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 2,638 shares of the company’s stock, valued at approximately $204,000.

Other large investors have also made changes to their positions in the company. Jennison Associates LLC grew its position in GE HealthCare Technologies by 49.4% in the fourth quarter. Jennison Associates LLC now owns 1,208,830 shares of the company’s stock worth $93,467,000 after acquiring an additional 399,961 shares in the last quarter. South Dakota Investment Council boosted its holdings in GE HealthCare Technologies by 272.1% in the fourth quarter. South Dakota Investment Council now owns 98,262 shares of the company’s stock worth $7,598,000 after purchasing an additional 71,857 shares in the last quarter. Cerity Partners LLC increased its position in GE HealthCare Technologies by 27.2% during the fourth quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock worth $3,551,000 after buying an additional 9,809 shares during the last quarter. Fifth Third Bancorp raised its holdings in GE HealthCare Technologies by 3.9% during the fourth quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock valued at $2,600,000 after buying an additional 1,250 shares in the last quarter. Finally, Douglas Lane & Associates LLC lifted its position in shares of GE HealthCare Technologies by 22.1% in the fourth quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock worth $33,731,000 after buying an additional 79,073 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 3.1 %

Shares of GEHC opened at $88.94 on Tuesday. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The firm has a market capitalization of $40.59 billion, a P/E ratio of 29.45, a P/E/G ratio of 3.00 and a beta of 0.95. The company has a 50-day simple moving average of $88.98 and a 200-day simple moving average of $78.75. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. The company had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. On average, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is 3.97%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Mizuho increased their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Morgan Stanley increased their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. HSBC assumed coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They set a “buy” rating and a $100.00 price objective for the company. Evercore ISI lifted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Finally, Argus upped their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.